1. Yoshimi, Akihide, Lin, Kuan-Ting, Wiseman, Daniel H, Krainer, Adrian R, Abdel-Wahab, Omar. 2019. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. In Nature, 574, 273-277. doi:10.1038/s41586-019-1618-0. https://pubmed.ncbi.nlm.nih.gov/31578525/
2. Wang, Zhiwei, Zhang, Cheng, Guo, Jing, Zhu, Pingping, He, Qiankun. 2024. CRISPR-Cas9 screening identifies INTS3 as an anti-apoptotic RNA-binding protein and therapeutic target for colorectal cancer. In iScience, 27, 109676. doi:10.1016/j.isci.2024.109676. https://pubmed.ncbi.nlm.nih.gov/38665208/
3. Vidhyasagar, Venkatasubramanian, He, Yujiong, Guo, Manhong, Lukong, Kiven E, Wu, Yuliang. 2018. Biochemical characterization of INTS3 and C9ORF80, two subunits of hNABP1/2 heterotrimeric complex in nucleic acid binding. In The Biochemical journal, 475, 45-60. doi:10.1042/BCJ20170351. https://pubmed.ncbi.nlm.nih.gov/29150435/
4. Matveeva, Elena A, Dhahri, Hejer, Fondufe-Mittendorf, Yvonne. 2022. PARP1's Involvement in RNA Polymerase II Elongation: Pausing and Releasing Regulation through the Integrator and Super Elongation Complex. In Cells, 11, . doi:10.3390/cells11203202. https://pubmed.ncbi.nlm.nih.gov/36291070/
5. Yang, Seungchan, Quaresma, Alexandre J C, Nickerson, Jeffrey A, van Wijnen, Andre J, Stein, Gary S. 2015. Subnuclear domain proteins in cancer cells support the functions of RUNX2 in the DNA damage response. In Journal of cell science, 128, 728-40. doi:10.1242/jcs.160051. https://pubmed.ncbi.nlm.nih.gov/25609707/
智鼠故事 
